• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗、群体免疫与2019冠状病毒病

Vaccines, Herd Immunity, and COVID-19.

作者信息

Washington-Brown Linda, Wimbish-Tompkins Rose

机构信息

President and Director of Xspurt Provider Services, a telehealth healthcare service. Since 1999, Dr. Washington-Brown is the retired founding Associate Dean for the RN to BSN Program at Broward College.

Program Manager of the RN to BSN Program at Broward College.

出版信息

ABNF J. 2021;32(2):42-46.

PMID:38515736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10957248/
Abstract

Vaccines in America have led to the eradication of transmissible infections and the reduction of vaccine preventable diseases among all age groups. Vaccines are important to the safety and welfare of our nation because vaccines produce immunity from infectious diseases. When most of the American population is vaccinated against COVID-19 and other transmittable diseases, herd or community immunity can slow disease transmission, including protection against the disease among persons who have not received the vaccines, and reduce the risk at-large of severe infections and adverse consequences of those diseases.

摘要

美国的疫苗已促成可传播感染的根除,并减少了所有年龄组中可通过疫苗预防的疾病。疫苗对我们国家的安全和福祉至关重要,因为疫苗可产生针对传染病的免疫力。当大多数美国人口接种针对新冠病毒和其他可传播疾病的疫苗时,群体免疫或社区免疫可减缓疾病传播,包括保护未接种疫苗的人群免受疾病侵害,并降低这些疾病严重感染和不良后果的总体风险。

相似文献

1
Vaccines, Herd Immunity, and COVID-19.疫苗、群体免疫与2019冠状病毒病
ABNF J. 2021;32(2):42-46.
2
Achieving herd immunity in South America.在南美洲实现群体免疫。
Glob Health Res Policy. 2023 Feb 1;8(1):2. doi: 10.1186/s41256-023-00286-2.
3
Will vaccine-derived protective immunity curtail COVID-19 variants in the US?疫苗衍生的保护性免疫能否在美国遏制新冠病毒变种?
Infect Dis Model. 2021;6:1110-1134. doi: 10.1016/j.idm.2021.08.008. Epub 2021 Sep 9.
4
Herd Immunity to Fight Against COVID-19: A Narrative Review.群体免疫对抗 COVID-19:一项叙述性综述。
Cureus. 2023 Jan 9;15(1):e33575. doi: 10.7759/cureus.33575. eCollection 2023 Jan.
5
Can Africa achieve herd immunity?非洲能否实现群体免疫?
Glob Health Res Policy. 2021 Dec 2;6(1):46. doi: 10.1186/s41256-021-00231-1.
6
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.SARS-CoV-2 引发非无菌免疫,逃避疫苗诱导的免疫:对未来疫苗接种策略的影响。
Eur J Epidemiol. 2023 Mar;38(3):237-242. doi: 10.1007/s10654-023-00965-x. Epub 2023 Feb 4.
7
Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World.预测美国、亚洲、欧洲、非洲、南美洲及全球范围内完全接种新冠疫苗的人数,并研究未来实现群体免疫所需的疫苗接种率。
Appl Soft Comput. 2021 Nov;111:107708. doi: 10.1016/j.asoc.2021.107708. Epub 2021 Jul 14.
8
Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.实现美国 COVID-19 疫苗衍生群体免疫阈值
Front Public Health. 2021 Jul 23;9:709369. doi: 10.3389/fpubh.2021.709369. eCollection 2021.
9
Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.对疫苗类型和免疫对 COVID-19 负担影响的批判性评估。
Math Biosci. 2023 Jun;360:108981. doi: 10.1016/j.mbs.2023.108981. Epub 2023 Feb 16.
10
Herd Immunity Against Coronavirus: A Review.群体免疫对抗冠状病毒:综述。
Recent Pat Biotechnol. 2022 Aug 3;16(3):256-265. doi: 10.2174/1872208316666220408113002.

引用本文的文献

1
Determinants of COVID-19 vaccine uptake among persons with disabilities in three selected districts of Zambia.赞比亚三个选定地区残疾人中新冠疫苗接种率的影响因素
PLOS Glob Public Health. 2025 Jul 7;5(7):e0003868. doi: 10.1371/journal.pgph.0003868. eCollection 2025.
2
Validation of an Arabic tool for assessing vaccination literacy: A factor and Rasch analysis.评估疫苗接种素养的阿拉伯语工具的验证:因子和 Rasch 分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2381297. doi: 10.1080/21645515.2024.2381297. Epub 2024 Jul 22.

本文引用的文献

1
The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines.科学依据在此:稳定基于病毒载体的新冠疫苗的关键考量因素
J Pharm Sci. 2021 Feb;110(2):627-634. doi: 10.1016/j.xphs.2020.11.015. Epub 2020 Nov 23.
2
Marked Reduction of Socioeconomic and Racial Disparities in Invasive Pneumococcal Disease Associated With Conjugate Pneumococcal Vaccines.肺炎球菌结合疫苗的应用显著降低了侵袭性肺炎球菌病相关的社会经济和种族差异。
J Infect Dis. 2021 Apr 8;223(7):1250-1259. doi: 10.1093/infdis/jiaa515.
3
High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity.甲型H1N1流感大流行期间儿童的高疫苗接种率是群体免疫的一个潜在因素。
Int J Environ Res Public Health. 2016 Oct 17;13(10):1017. doi: 10.3390/ijerph13101017.
4
Multivalent and Multipathogen Viral Vector Vaccines.多价和多病原体病毒载体疫苗
Clin Vaccine Immunol. 2017 Jan 5;24(1). doi: 10.1128/CVI.00298-16. Print 2017 Jan.
5
Immunization in the United States: Recommendations, Barriers, and Measures to Improve Compliance: Part 2: Adult Vaccinations.美国的免疫接种:建议、障碍及提高依从性的措施:第2部分:成人疫苗接种
P T. 2016 Aug;41(8):492-506.
6
"Herd immunity": a rough guide.群体免疫:一个粗略的指南。
Clin Infect Dis. 2011 Apr 1;52(7):911-6. doi: 10.1093/cid/cir007.